Susan Mango  by Mango, Susan
Current Biology Vol 19 No 7
R276
Technological Research Council 
(Tubitak). The magazine’s editor, 
Cigdem Atakuman, was also sacked 
for ‘exceeding her authority’ by 
commissioning the article, which 
the council said was “not planned or 
scientifically evaluated beforehand”. 
The government has denied 
playing any role in the article’s 
withdrawal and has joined in the 
condemnation, despite its well-
known opposition to evolutionary 
theory. Mehmet Aydin, the minister 
responsible for Tubitak, said that 
it had been guilty of censorship. 
Tubitak “is supposed to reflect the 
views of all those who have served 
science,” he said. “No matter how 
mistaken they can be.” 
But the publicity arising out of 
these events in Turkey may have 
worked against the government. The 
sacked editor, Atakuman, told Der 
Spiegel that “the whole affair has 
created awareness of Darwin. Many 
people now want to get informed. 
There will be many events in Turkey 
commemorating Darwin’s 200th 
birthday”.
It now appears, following these 
events, that Atakuman has been 
reinstated as editor of the journal 
but believes the incident has hurt 
the reputation of Turkish science and 
scientists in the international arena.
Back in Lisbon, the exhibition 
is accompanied by a series of 
eight public lectures on biology 
and evolution by internationally 
renowned scientists, including 
Rosemary and Peter Grant talking 
about the evolution of Darwin’s 
finches.
“This museum is a house of culture 
where all its facets can be merged 
in the same space,” says Caraça. 
And the Darwin exhibition is in the 
company of one of Europe’s finest 
art collections. Calouste Gulbenkian 
was a wealthy oil magnate and most 
of his artistic acquisitions are now 
held here. “We must ensure that 
scientific culture is not separated 
from the rest of culture, but rather 
that it becomes mainstream.” So 
far the exhibition has been a great 
success. More than 10,000 people 
visited in the first week with a total 
of 50,000 for the first month. “This 
makes it one of the most visited 
Darwin exhibitions ever,” says Feijó, 
“even compared with cities that have 
more inhabitants than our whole 
country.”Susan Mango 
Susan Mango is Benning Professor of 
Oncological Sciences at the University 
of Utah and an Investigator at the 
Huntsman Cancer Institute. She 
grew up in England and Washington 
D.C. before attending Harvard 
University. She received her Ph.D. 
from Princeton, where she studied the 
c-myc oncogene with Michael Cole. 
She was introduced to the nematode 
Caenorhabditis elegans as a postdoc 
with Judith Kimble at the University 
of Wisconsin – Madison, and moved 
to Utah in 1996 to start her own lab. 
After 13 years at the University of Utah, 
she will move to Harvard University 
in July 2009. Her principal focus is 
transcriptional strategies of organ 
development, using the C. elegans 
foregut as a model.
How did you get involved in biology? 
I always enjoyed biology, but there 
were two experiences that brought me 
to graduate school. One was during 
high school. I won a scholarship from 
the ACS to work in a lab — my first lab 
experience. I had always liked biology, 
but hadn’t considered a career in 
science because I imagined lab life to 
be exceptionally dull. My vision was 
silent scientists dressed in white lab 
coats, carrying clipboards. Instead, in 
the lab of John Hallenbeck at the Naval 
Medical Center, I found a lively crew 
of people with the radio blaring, and 
my first opportunity to work a pipette. 
I still believe that to get kids interested 
in science we need to show them how 
exciting it is and to introduce them to 
the feeling of discovery. 
My second experience was after 
college. I enjoyed science, but I also 
loved the arts and thought I could 
combine those interests by becoming 
an art conservator. I talked myself 
into a job in the art conservation 
department of the National Gallery of 
Art in Washington D.C. It was great fun 
to poke my nose into the Rembrandts 
and to figure out whether the white 
fuzz on a painting was mold or a 
chemical precipitate. But eventually 
I missed the logic of science. A lot of 
people go into biology because they 
love nature. Not me. I loved biology 
because of the puzzles and the 
challenge of designing experiments 
Q & A to answer questions. Still, the art side lingers, and, to this day, I think in 
pictures. Blobs of proteins moving on 
wiggly lines of DNA, like a Japanese 
anime movie in my head. 
What are some of your memorable 
moments in science? There have 
been many, but I’ll tell you about 
three. One was the decision to work 
on the C. elegans pha-4 gene, which 
encodes a FoxA transcription factor 
and is a central focus of my lab. I 
was a postdoc with Judith Kimble in 
Madison, Wisconsin, trying to choose a 
project that I could ultimately take with 
me to start my own lab. When I saw 
the pha-4 worm, I was hooked — it is 
a beautiful mutant. The pha-4 gene is 
required to form the foregut, and pha-4 
mutants arrest as little larvae that look 
normal except the foregut is gone. 
Staring at pha-4 got me thinking about 
organogenesis, an under-explored 
area at the time. No one had taken an 
unbiased, forward genetics approach 
to study organs and, today, there 
are still many fascinating questions 
to answer. The pha-4 phenotype 
suggested the surprising possibility 
that, just as we consider an organ to 
be an entity, an organizational unit, 
nature does as well. 
A few years later we were searching 
for PHA-4 target genes. We were using 
microarray to find genes expressed in 
the foregut and testing those genes 
to determine which were regulated by 
PHA-4 directly. As we scanned a list 
of microarray positives for those that 
had canonical PHA-4 binding sites in 
their predicted promoters, we noticed 
that all the highly expressed genes had 
sites, whereas the genes lower down 
the list did not. This perplexing result 
ultimately led to our discovery that the 
affinity of PHA-4 binding influences 
the timing of expression in the foregut. 
I still remember looking at the list of 
genes and having a Eureka moment. 
It is always exciting to meet 
someone whose work you’ve read 
and admired. And sometimes it is 
such a surprise. I remember my first 
Gordon Research Conference. I was 
sharing a room with a mysterious 
person who had arrived from 
Europe — obvious from the bags 
decorated in German — and who 
was fast asleep in bed. It wasn’t until 
later that day that I discovered my 
roommate was Janni Nüsslein-Volhard: 
Nobel laureate, jet-lagged and slightly 
resembling my mother. 
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because of their peptidoglycan cell 
walls; they have bacterial-sized 
ribosomes sensitive to the usual 
antibiotics; and they do not contain 
organelles such as chloroplasts and 
mitochondria. A major consequence 
of the name change was to remove 
this vast array of organisms from 
the realm of botany and to put them 
into the microbial world (Bergey’s 
Manual). Figure 1 shows an electron 
micrograph of a section through a 
cyanobacterial cell, revealing the 
photosynthetic membranes and 
numerous ribosomes.
Are they really old? This is still an 
open question. There are certainly 
ancient rocks, say 1.5 billion years 
old, that contain tracks of connected 
objects which look as though 
they could be cell-wall ghosts 
of contemporary cyanobacteria. 
Unfortunately there is no chemical 
trace associated with these objects, 
Cyanobacteria
Robert Haselkorn
What’s in a name? Before 1960, 
the organisms we know today 
as cyanobacteria were called 
blue- green algae. They were 
classified along with the green 
algae, the red algae, and the brown 
algae as photosynthetic microbes. 
It was universally agreed that all 
of these carried out green plant 
photosynthesis, fixing CO2 and 
generating O2 from water. But in 
the 1960s it became apparent, 
from new biochemical evidence, 
that the blue-green algae, unlike 
the other algae, are really bacteria: 
they are sensitive to penicillin 
Quick guides
Figure 1. Electron micrograph of a section through Anabaena. 
The sample was prepared by high-pressure freezing, freeze-substituted, stained and sectioned 
as described in: Plastoglobules are lipoprotein subcompartments of the chloroplast that are 
permanently coupled to thylakoid membranes and contain biosynthetic enzymes. Austin II, 
J.R., Frost, E., Vidi, P.A., Kessler, F., and Staehelin, L.A. (2006). Plant Cell 18, 1693-1703. The 
bar represents 1 micron. (Figure courtesy of J.R. Austin and Z. Ye.)Any embarrassing moments? 
Yes. In my first year as an assistant 
professor I was asked to give a talk in a 
neighboring department. They had just 
moved to a new building and I was the 
first speaker in their new auditorium. 
As I started my talk, we discovered 
that the auditorium was so new there 
weren’t any light switches. I couldn’t 
turn off the lights, and my slides 
were invisible. All those hours spent 
preparing my talk were for naught, and 
instead I gave a chalk talk with a lot of 
fuzzy sketches!
Any good advice you can pass on 
to young scientists? As a graduate 
student I met Ira Herskowitz, and he 
said this: “as you think about your 
data, keep your foot on the ground. But 
only one foot!” That saying reminds 
me of the movie Brazil and the idea of 
being grounded, but also letting your 
ideas take flight. I also remember what 
a lonely time it was when I started my 
own lab. The silver lining was that I had 
a lot of time to myself to think about 
my science and to do experiments. So 
my third piece of advice, especially to 
struggling junior faculty, is to focus on 
the biology. If you do good science, 
everything else will work itself out.
What do you see as an issue for 
the sciences in future years? One 
area that I’m concerned about is the 
organization of our labs. The idea of a 
lab filled with graduate students and 
postdocs was born at a time when 
we wanted the sciences to expand 
rapidly. It was an effective way to 
train young scientists and to get work 
done at low cost. But today, we are 
at a steady state, and we don’t need 
to generate hundreds of new labs. 
Instead we should consider how to 
balance the need for job opportunities 
and funding for students and postdocs 
with the need for a vibrant workforce 
in the lab. Some of those challenges 
we’ve met with better support for 
postdocs, different review processes 
for junior faculty at the NIH. Maybe we 
also need to train fewer students and 
postdocs and to increase the number 
of permanent positions in our labs. 
The problem is not solved yet and 
will probably require some creative 
thinking. 
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